极早产儿新生儿期血糖指标与新生儿疾病及2岁结局的关系
该回顾性观察队列研究纳入443例出生体重<1500g或胎龄<30周的极早产儿,按第一周血糖绝对波动分为正常血糖、低血糖、高血糖和不稳定四组。高血糖和不稳定组无新生儿疾病存活及2岁无神经发育损害存活的可能性更低,但校正胎龄、出生体重z评分和社会经济状况后,血糖指标与新生儿疾病或2岁结局均无关联。结论认为极早产儿血糖指标是胎龄和宫内生长的标志,并非新生儿疾病或2岁结局的独立预测因素。
要点
- 高血糖和不稳定组无新生儿疾病存活及2岁无神经发育损害存活的可能性更低。
- 低血糖组新生儿及2岁结局与正常血糖组相似。
- 血糖指标与结局的关联在校正胎龄、出生体重z评分和社会经济状况后均消失。
核心结论
- 极早产儿新生儿期血糖指标是胎龄和宫内生长的标志,并非新生儿疾病或2岁结局的独立预测因素。
研究设计与样本
- 回顾性观察队列研究,纳入443例出生体重<1500g或胎龄<30周、生后24小时内入住新西兰奥克兰国家妇女医院的极早产儿。
- 以第一周血糖绝对波动将婴儿分为正常血糖、低血糖、高血糖和不稳定四组。
- 血糖变异性定义为所有血糖浓度对数转换后围绕均值的标准差。
主要发现
- 与正常血糖组相比,低血糖组和不稳定组出生体重z评分更低,高血糖组和不稳定组出生体重更低。
- 低血糖组新生儿及2岁结局与正常血糖组相似。
- 高血糖组和不稳定组无新生儿疾病存活及2岁无神经发育损害存活的可能性更低。
- 高血糖组和不稳定组平均血糖更高,且与更差的新生儿及2岁结局相关。
- 低血糖组和不稳定组血糖变异性更大,且与更差的新生儿疾病相关,但与2岁结局无关。
临床怎么用
- 极早产儿血糖指标异常应结合胎龄、出生体重z评分和社会经济状况综合解读,不宜单独作为预后判断依据。
局限性
- 单中心回顾性观察设计,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate relationships between early neonatal glycemia, neonatal characteristics, neonatal illness, and developmental outcomes in very preterm infants. STUDY DESIGN: A retrospective, observational cohort study of 443 infants born weighing <1500 g or <30 weeks of gestation, and admitted within 24 hours to National Women's Hospital, Auckland, New Zealand. Glucose variability was defined as the standard deviation around the mean after log transformation of all blood glucose concentrations. Absolute glycemic excursions in the first week were used to divide the infants into 4 groups: normoglycemic; hypoglycemic; hyperglycemic, and unstable. RESULTS: Compared with normoglycemic infants, hypoglycemic and unstable infants had lower birth weight z-scores, and hyperglycemic and unstable infants were of lower birth weight. Hypoglycemic infants had similar outcomes to normoglycemic infants. Hyperglycemic and unstable infants were less likely to survive without neonatal morbidity and less likely to survive without neurodevelopmental impairment at 2 years of age. Higher mean blood glucose concentration was seen in the hyperglycemic and unstable groups, and was associated with worse neonatal and 2-year outcomes. Greater glucose variability was seen in the hypoglycemic and unstable groups, and was associated with worse neonatal illness but not outcome at 2 years. No associations between measures of neonatal glycemia and neonatal or 2-year outcomes remained after correction for gestation, birth weight z-score, and socioeconomic status. CONCLUSIONS: In very preterm infants, measures of neonatal glycemia are markers of gestational age and intrauterine growth, and are not independent predictors of neonatal illness or outcomes at 2 years of age.
引用
- Tottman AC, Alsweiler JM, Bloomfield FH, et al. Relationship between Measures of Neonatal Glycemia, Neonatal Illness, and 2-Year Outcomes in Very Preterm Infants. J Pediatr. 2017. PMID: 28647271. doi:10.1016/j.jpeds.2017.05.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。